2014
DOI: 10.1001/jama.2014.9405
|View full text |Cite
|
Sign up to set email alerts
|

Management of Persistent Pain in the Older Patient

Abstract: Importance Persistent pain is highly prevalent, costly, and frequently disabling in later life. Objective To describe barriers to the management of persistent pain among older adults, summarize current management approaches, including pharmacologic and nonpharmacologic modalities; present rehabilitative approaches; and highlight aspects of the patient-physician relationship that can help to improve treatment outcomes. This review is relevant for physicians who seek an age-appropriate approach to delivering p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
201
0
10

Year Published

2015
2015
2022
2022

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 263 publications
(218 citation statements)
references
References 103 publications
3
201
0
10
Order By: Relevance
“…NSAIDs are commonly used for rheumatic diseases and persistent pain due to orthopedic diseases (5,6). Rheumatic diseases have an autoimmune basis and affect connective tissue (6,7).…”
Section: Introductionmentioning
confidence: 99%
“…NSAIDs are commonly used for rheumatic diseases and persistent pain due to orthopedic diseases (5,6). Rheumatic diseases have an autoimmune basis and affect connective tissue (6,7).…”
Section: Introductionmentioning
confidence: 99%
“…Недооценка низкого комплаенса, особенно при боле-вом синдроме, у пациентов с ОА ведет к неправильной тактике лечения: коррекции терапии, увеличению доз препаратов и необоснованной госпитализации [17,18].…”
Section: препараты ингибирующие цог-2 влияют на редукцию воспаленияunclassified
“…8,34,[41][42][43][44] As a result, a recent clinical review recommends initiating long-term opioid therapy only when patients have moderate to severe pain leading to substantial impairment in daily living and when all other treatment modalities have failed. 45 This is not a recommendation founded on demonstrable evidence of benefits exceeding harms. Moreover, these guidelines are often not observed in clinical practice, as many practitioners continue to initiate opioids as a first-line therapy in the treatment of various chronic pain syndromes.…”
Section: Harms Of Therapymentioning
confidence: 99%